Teachers Advisors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Teachers Advisors’s Portfolio GEVA Stock Details GEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-32,505	Closed	-$3.17M	–	3217
2015 Q1	$3.17M	Buy	32,505 +2,356	+8%	+$249K	0.01%	1373
2014 Q4	$2.8M	Hold	30,149	–	–	0.01%	1414
2014 Q3	$2.07M	Hold	30,149	–	–	﹤0.01%	1574
2014 Q2	$3.16M	Buy	30,149 +1,626	+6%	+$138K	0.01%	1336
2014 Q1	$2.37M	Buy	28,523 +2,270	+9%	+$210K	0.01%	1465
2013 Q4	$1.7M	Buy	26,253 +2,670	+11%	+$158K	﹤0.01%	1661
2013 Q3	$1.49M	Buy	23,583 +1,069	+5%	+$52.6K	﹤0.01%	1672
2013 Q2	$946K	Buy	+22,514	New	+$1.03M	﹤0.01%	1886

Teachers Advisors's GEVA Position: Q2 2015 in Review

Teachers Advisors sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 32,505 shares — an estimated $3.17M sold.

Teachers Advisors first reported a position in GEVA in Q2 2013 and held it in 8 quarters. The position peaked at $3.17M in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

Teachers Advisors reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Teachers Advisors sold 32,505 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $3.17M.
Teachers Advisors first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2013 and held it in 8 quarters.
Teachers Advisors's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $3.17M in Q1 2015.
0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Teachers Advisors's 13F filing for Q2 2015, filed 10 Aug 2015.